Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Ana Martinez-naharro"'
Autor:
Adam Ioannou, Christian Nitsche, Aldostefano Porcari, Rishi K. Patel, Yousuf Razvi, Muhammad U. Rauf, Ana Martinez‐Naharro, Lucia Venneri, Antonella Accietto, Lucrezia Netti, Francesco Bandera, Ruta Virsinskaite, Tushar Kotecha, Dan Knight, Aviva Petrie, Carol Whelan, Ashutosh Wechalekar, Helen Lachmann, Philip N. Hawkins, Julian D. Gillmore, Marianna Fontana
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Background Transthyretin cardiac amyloidosis (ATTR‐CA) is a progressive and ultimately fatal cardiomyopathy. Biomarkers reflecting multiorgan dysfunction are of increasing importance in patients with heart failure; however, their significance in AT
Externí odkaz:
https://doaj.org/article/5da03ace9bff4944a71e3745bf41b76f
Autor:
Jahanzaib Khwaja, Sriram Ravichandran, Joshua Bomsztyk, Oliver Cohen, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Marianna Fontana, Philip N. Hawkins, Julian Gillmore, Helen J. Lachmann, Shameem Mahmood, Carol Whelan, Amy A. Kirkwood, Ashutosh Wechalekar
Publikováno v:
Haematologica, Vol 109, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/915c492f78c44f6384e3417ca3c0700e
Autor:
Yousuf Razvi, Aldostefano Porcari, Concetta Di Nora, Rishi K. Patel, Adam Ioannou, Muhammad U. Rauf, Ambra Masi, Steven Law, Liza Chacko, Tamer Rezk, Sriram Ravichandran, Janet Gilbertson, Dorota Rowczenio, Iona J. Blakeney, Nandita Kaza, David F. Hutt, Helen Lachmann, Ashutosh Wechalekar, William Moody, Sern Lim, Colin Chue, Carol Whelan, Lucia Venneri, Ana Martinez-Naharro, Marco Merlo, Gianfranco Sinagra, Ugolino Livi, Philip Hawkins, Marianna Fontana, Julian D. Gillmore
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2023)
AimsTransthyretin cardiac amyloidosis (ATTR-CM) is a progressive and fatal cardiomyopathy. Treatment options in patients with advanced ATTR-CM are limited to cardiac transplantation (CT). Despite case series demonstrating comparable outcomes with CT
Externí odkaz:
https://doaj.org/article/dcd42138c72146719916644456120435
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
Autor:
Sriram Ravichandran, Oliver C. Cohen, Steven Law, Darren Foard, Marianna Fontana, Ana Martinez-Naharro, Carol Whelan, Julian D. Gillmore, Helen J. Lachmann, Sajitha Sachchithanantham, Shameem Mahmood, Philip N. Hawkins, Ashutosh D. Wechalekar
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-9 (2021)
Abstract The outcomes in systemic AL amyloidosis are dependent on the depth of haematologic response. However, there is limited data on the impact of the speed of response on outcomes. Here we report the impact of speed of response in a cohort of AL
Externí odkaz:
https://doaj.org/article/b337fd1300e6447c92566346cf8407bf
Autor:
Steven Law, Aviva Petrie, Liza Chacko, Oliver C. Cohen, Sriram Ravichandran, Janet A. Gilbertson, Dorota Rowczenio, Ashutosh Wechalekar, Ana Martinez‐Naharro, Helen J. Lachmann, Carol J. Whelan, David F. Hutt, Philip N. Hawkins, Marianna Fontana, Julian D. Gillmore
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3942-3949 (2020)
Abstract Aims Cardiac transthyretin amyloidosis (ATTR‐CM) is a progressive and fatal condition. Prognosis can be determined at diagnosis according to the National Amyloidosis Centre (NAC) transthyretin amyloidosis (ATTR) stage. We sought to examine
Externí odkaz:
https://doaj.org/article/5ca588ecccb047eab238fa32476e0c62
Autor:
Daniel S. Knight, Tushar Kotecha, Ana Martinez-Naharro, James T. Brown, Michele Bertelli, Marianna Fontana, Vivek Muthurangu, J. Gerry Coghlan
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 21, Iss 1, Pp 1-11 (2019)
Abstract Background Cardiovascular magnetic resonance imaging (CMR) is valuable for the investigation and management of pulmonary artery hypertension (PAH), but the direct measurement of pulmonary hemodynamics by right heart catheterization is still
Externí odkaz:
https://doaj.org/article/d0f081bb84da4717be31b2b18874576c
Autor:
Faye A. Sharpley, Marianna Fontana, Ana Martinez-Naharro, Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham, Helen J. Lachmann, Julian D. Gillmore, Carol J. Whelan, Philip N. Hawkins, Ashutosh D. Wechalekar
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Patients with systemic immunoglobulin light chain amyloidosis (AL) with no evidence of cardiac involvement by consensus criteria have excellent survival, but 20% will die within 5 years of diagnosis and prognostic factors remain poorly characterised.
Externí odkaz:
https://doaj.org/article/4c0d2fdc319441b7ad5798507526abd1
Autor:
Wenguang Li, Alan Lazarus, Hao Gao, Ana Martinez-Naharro, Marianna Fontana, Philip Hawkins, Swethajit Biswas, Robert Janiczek, Jennifer Cox, Colin Berry, Dirk Husmeier, Xiaoyu Luo
Publikováno v:
Frontiers in Physiology, Vol 11 (2020)
Deposition of amyloid in the heart can lead to cardiac dilation and impair its pumping ability. This ultimately leads to heart failure with worsening symptoms of breathlessness and fatigue due to the progressive loss of elasticity of the myocardium.
Externí odkaz:
https://doaj.org/article/cbc6f7a10db14931bfcbc2097d57b075
Autor:
Michele Orini, Adam J. Graham, Ana Martinez‐Naharro, Christopher M. Andrews, Antonio de Marvao, Ben Statton, Stuart A. Cook, Declan P. O'Regan, Philip N. Hawkins, Yoram Rudy, Marianna Fontana, Pier D. Lambiase
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 18 (2019)
Background The relationship between structural pathology and electrophysiological substrate in cardiac amyloidosis is unclear. Differences between light‐chain (AL) and transthyretin (ATTR) cardiac amyloidosis may have prognostic implications. Metho
Externí odkaz:
https://doaj.org/article/1be7cbba64f24c538ac1f3755c5fef54
Autor:
Rohin Francis, Peter Kellman, Tushar Kotecha, Andrea Baggiano, Karl Norrington, Ana Martinez-Naharro, Sabrina Nordin, Daniel S. Knight, Roby D. Rakhit, Tim Lockie, Philip N. Hawkins, James C. Moon, Derek J. Hausenloy, Hui Xue, Michael S. Hansen, Marianna Fontana
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 19, Iss 1, Pp 1-12 (2017)
Abstract Background Conventional bright blood late gadolinium enhancement (bright blood LGE) imaging is a routine cardiovascular magnetic resonance (CMR) technique offering excellent contrast between areas of LGE and normal myocardium. However, contr
Externí odkaz:
https://doaj.org/article/bf9c207196e644c7a12d1a7c58da1cd8